Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Infect Control Hosp Epidemiol ; 41(11): 1344-1347, 2020 11.
Article in English | MEDLINE | ID: mdl-32600491

ABSTRACT

Engagement of frontline staff, along with senior leadership, in competition-style healthcare-associated infection reduction efforts, combined with electronic clinical decision support tools, appeared to reduce antibiotic regimen initiations for urinary tract infections (P = .01). Mean monthly standardized infection and device utilization ratios also decreased (P < .003 and P < .0001, respectively).


Subject(s)
Catheter-Related Infections , Cross Infection , Urinary Tract Infections , Anti-Bacterial Agents/therapeutic use , Catheter-Related Infections/drug therapy , Cross Infection/drug therapy , Cross Infection/prevention & control , Equipment and Supplies , Humans , Urinary Tract Infections/drug therapy
2.
J Pediatric Infect Dis Soc ; 8(3): 269-271, 2019 Jul 01.
Article in English | MEDLINE | ID: mdl-30107596

ABSTRACT

Elizabethkingia spp are Gram-negative bacteria associated with neonatal meningitis. In 2015-2016, an outbreak of Elizabethkingia anophelis infection that involved 63 patients and 18 deaths occurred in Wisconsin. Despite a multistate investigation, as of September 2016 the source remained undetermined, and experts warned of reemergence. We describe here the first cases of E anophelis infection in New York, including the case of a healthy infant without previous healthcare contact.


Subject(s)
Cross Infection/microbiology , Flavobacteriaceae Infections/microbiology , Flavobacteriaceae/genetics , Flavobacteriaceae/isolation & purification , Adult , Aged , Case-Control Studies , Cross Infection/diagnosis , Cross Infection/epidemiology , Female , Flavobacteriaceae Infections/diagnosis , Flavobacteriaceae Infections/epidemiology , Genomics , Humans , Infant , Male , New York/epidemiology , Phylogeny , Sequence Analysis, DNA
4.
Open Forum Infect Dis ; 2(3): ofv093, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26213692

ABSTRACT

Background. The contemporary Staphylococcus aureus clonal complex (CC) 30 lineage is associated with complicated infections, including endocarditis and osteomyelitis. This lineage diverged from the phage-type 80/81 S aureus clone responsible for a major bacterial epidemic of the 20th century. The genome and transcriptome features that contribute to complicated infections of the CC30 lineage are unknown. Methods. Twenty-nine clinical methicillin-resistant S aureus (MRSA) strains (8 from CC30 and 21 from other major CCs were evaluated for virulence using murine and Galleria mellonella sepsis models. Genomic features of CC30 were identified by comparative genome sequencing and RNA-Seq transcriptome analysis of the 29 strains and 31 previously sequenced S aureus genomes. Results. The CC30 isolates displayed lower virulence in the sepsis models compared with other CCs [P < .0001]. Comparisons of orthologous proteins and transcriptome analysis identified genes (eg, nitric oxide reductase) and changes in metabolic pathways (eg, pyrimidine metabolism) that contribute to the distinct CC30 phenotype. Previously reported nonsynonymous single-nucleotide polymorphisms (SNPs) were found in accessory gene regulator C (agrC) and α-hemolysin (hla), molecules important for virulence. Additional nonsynonymous SNPs conserved across clinical CC30 isolates when compared with the first sequenced contemporary CC30 clone, MRSA-16, were identified in multiple genes, suggesting continuing evolutionary divergence in this lineage. Conclusions. Genomic and transcriptional analyses suggest that the CC30 lineage has acquired metabolic features that contribute to persistent and complicated infections. Absence of sepsis-induced mortality in animal models may be due in part to its unique genomic profile and suggests that specific genotypes of S aureus elicit distinct types of infection types.

5.
J Bacteriol ; 195(3): 615-28, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23204459

ABSTRACT

Pathogen evolution and subsequent phenotypic heterogeneity during chronic infection are proposed to enhance Staphylococcus aureus survival during human infection. We tested this theory by genetically and phenotypically characterizing strains with mutations constructed in the mismatch repair (MMR) and oxidized guanine (GO) system, termed mutators, which exhibit increased spontaneous-mutation frequencies. Analysis of these mutators revealed not only strain-dependent increases in the spontaneous-mutation frequency but also shifts in mutational type and hot spots consistent with loss of GO or MMR functions. Although the GO and MMR systems are relied upon in some bacterial species to prevent reactive oxygen species-induced DNA damage, no deficit in hydrogen peroxide sensitivity was found when either of these DNA repair pathways was lost in S. aureus. To gain insight into the contribution of increased mutation supply to S. aureus pathoadaptation, we measured the rate of α-hemolysin and staphyloxanthin inactivation during serial passage. Detection of increased rates of α-hemolysin and staphyloxanthin inactivation in GO and MMR mutants suggests that these strains are capable of modifying virulence phenotypes implicated in mediating infection. Accelerated derivation of altered virulence phenotypes, combined with the absence of increased ROS sensitivity, highlights the potential of mutators to drive pathoadaptation in the host and serve as catalysts for persistent infections.


Subject(s)
Mutation , Staphylococcus aureus/genetics , Adaptation, Physiological/genetics , Bacterial Toxins/genetics , Bacterial Toxins/metabolism , Base Sequence , DNA Damage , DNA Mismatch Repair/genetics , DNA, Bacterial/genetics , Gene Expression Regulation, Bacterial/physiology , Guanine/metabolism , Hemolysin Proteins/genetics , Hemolysin Proteins/metabolism , Hydrogen Peroxide , Molecular Sequence Data , Oxidation-Reduction , Reactive Oxygen Species , Staphylococcus aureus/metabolism , Staphylococcus aureus/physiology , Time Factors , Virulence Factors/biosynthesis , Virulence Factors/genetics , Xanthophylls/genetics , Xanthophylls/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...